PAFAH1B3 and hepatocellular carcinoma: To further explore whether PAFAH1B3 can be used as a target for the treatment of HCC, we tested the proliferation of HepG2, Huh7 and MHCC-97H cells after silencing or pharmacologic inhibitor of PAFAH1B3.